Page last updated: 2024-09-05

sch 58261 and istradefylline

sch 58261 has been researched along with istradefylline in 2 studies

Compound Research Comparison

Studies
(sch 58261)
Trials
(sch 58261)
Recent Studies (post-2010)
(sch 58261)
Studies
(istradefylline)
Trials
(istradefylline)
Recent Studies (post-2010) (istradefylline)
4601421218121

Protein Interaction Comparison

ProteinTaxonomysch 58261 (IC50)istradefylline (IC50)
Adenosine receptor A2aHomo sapiens (human)5.249
Adenosine receptor A2aRattus norvegicus (Norway rat)0.228

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
de Lera Ruiz, M; Lim, YH; Zheng, J1
Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G1

Reviews

2 review(s) available for sch 58261 and istradefylline

ArticleYear
Adenosine A2A receptor as a drug discovery target.
    Journal of medicinal chemistry, 2014, May-08, Volume: 57, Issue:9

    Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction

2014
Adenosine receptor antagonists: Recent advances and therapeutic perspective.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship

2022